Form D · Pharmaceuticals
Lumos Pharma, Inc.
Austin, TX · CIK 0001596584
Offering snapshot reported Apr 18, 2016 · SEC filing
- Reported sold
- $34M Offering amount: $34M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 4, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 18, 2016 | Initial | $33,999,991 | No comparison | 6 | SEC filing |
| May 1, 2015 | Amendment | $13,000,000 | $6,500,000vs Feb 6, 2014 | 5 | SEC filing |
| Feb 6, 2014 | Initial | $6,500,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-261574
Source: Form D, filed Apr 18, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| G. Gilbert Cloyd | Director |
| George Gilbert Cloyd | Director |
| Richard John Hawkins | Director, Executive |
| Robert Heft | Director |
| Kevin M. Lalande | Director |
| Kevin Lelande | Director |
| Edward Mathers | Director |
| Michele Park | Director |
| Jon S. Saxe | Director |
| Tracy Saxton | Director |
| Cameron Wheeler | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
4200 Marathon Blvd., Suite 200
Austin, TX, 78756
Austin, TX, 78756